Award winning hybrid vascular graft earns CE Mark
Published date : 29 August 2012
Article date : 23 August 2012
WL Gore and Associates has announced that its award-winning Gore Hybrid Vascular Graft has been granted the CE Mark approval. The device has been available in the US since 2010 and has been proven to expand treatment options for optimal outflow by maximising the number of access sites available.
Designed as a vascular prosthesis for replacement or bypass of diseased vessels impacted by aortic aneurysmal, peripheral vascular and end-stage renal disease, it is able to address common causes of graft failure, such as intimal hyperplasia, thrombosis and seroma.
More than 2,500 successful implants for dialysis access and other vascular procedures have taken place since the product's US debut.
The company took gold for the device at the 2012 Medical Design Excellence Awards, in July.
Source: Medical Company Product News, 22 August 2012
Read more here